NatWest Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-24,780
Closed -$446K 201
2015
Q3
$446K Buy
+24,780
New +$569K 0.01% 294
2015
Q2
Sell
-24,780
Closed -$546K 395
2015
Q1
$546K Buy
24,780
+256
+1% +$6.49K 0.01% 311
2014
Q4
$673 Sell
24,524
-41,595
-63% -$1.01M 0.01% 269
2014
Q3
$1.28K Sell
66,119
-14,751
-18% -$270K 0.01% 233
2014
Q2
$1.38M Buy
80,870
+3,146
+4% +$43.3K 0.06% 230
2014
Q1
$1.1M Sell
77,724
-11,945
-13% -$161K 0.05% 233
2013
Q4
$1.05M Buy
89,669
+19,456
+28% +$223K 0.03% 427
2013
Q3
$829K Buy
+70,213
New +$901K 0.02% 496

Other funds holding EXAS

NatWest Group's EXAS Position: Q4 2015 in Review

NatWest Group sold out of Exact Sciences (EXAS) in Q4 2015, closing a stake of 24,780 shares — an estimated $446K sold.

NatWest Group first reported a position in EXAS in Q3 2013 and held it in 8 quarters. The position peaked at $1.38M in Q2 2014. 183 funds tracked by Wall St. Rank hold EXAS as of Q4 2015.

  • NatWest Group reported no remaining Exact Sciences position as of Q4 2015 after selling out during the quarter.
  • NatWest Group sold 24,780 Exact Sciences shares in Q4 2015, an estimated $446K.
  • NatWest Group first reported a position in Exact Sciences in Q3 2013 and held it in 8 quarters.
  • NatWest Group's Exact Sciences position peaked at $1.38M in Q2 2014.
  • 183 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.